Which finding best differentiates acetylcholinesterase inhibitor toxicity from organophosphate poisoning at the synaptic level?

Explanation

## Acetylcholinesterase Inhibitor Toxicity vs Organophosphate Poisoning ### Mechanism of Enzyme Inhibition | Aspect | Therapeutic AChE Inhibitors | Organophosphate Poisoning | |--------|----------------------------|---------------------------| | **Mechanism** | Reversible carbamylation of serine in active site | Irreversible phosphorylation (phosphorylation) of serine | | **Duration of Effect** | Hours to days (reversible) | Days to weeks (irreversible); "aging" occurs | | **Enzyme Recovery** | Spontaneous hydrolysis of carbamate bond | Requires new enzyme synthesis; aging prevents reactivation | | **Antidote** | Supportive care; no specific reactivator needed | Pralidoxime (2-PAM) if given early; atropine for muscarinic symptoms | | **Clinical Signs** | Both muscarinic AND nicotinic (cholinergic crisis) | Both muscarinic AND nicotinic (cholinergic crisis) | | **Severity** | Dose-dependent, usually reversible | Often severe; may be irreversible if "aging" occurs | ### Key Point: **The critical biochemical distinction is the nature of the covalent bond formed with acetylcholinesterase: therapeutic inhibitors form reversible carbamate esters, while organophosphates form irreversible phosphoramide bonds.** This difference determines whether the enzyme can recover spontaneously or requires new protein synthesis. ### High-Yield: **Organophosphate "aging"** is a time-dependent process in which the phosphorylated enzyme undergoes dealkylation, making it resistant to pralidoxime reactivation. Once aging occurs (minutes to hours depending on the agent), pralidoxime is ineffective, and recovery depends entirely on new enzyme synthesis (days to weeks). This is why early pralidoxime administration is critical in organophosphate poisoning. ### Mnemonic: **CARB-PHOS** - **CARB**amylation = **Reversible** (therapeutic AChE inhibitors: neostigmine, pyridostigmine, edrophonium) - **PHOS**phorylation = **Irreversible** (organophosphates: parathion, malathion, sarin) ### Clinical Pearl: Both conditions present with **cholinergic crisis** (muscarinic: miosis, bronchospasm, bradycardia, diarrhea; nicotinic: fasciculations, paralysis, tachycardia). The clinical presentation is nearly identical — the distinction is biochemical and determines management (pralidoxime is useful in organophosphate poisoning if given early, but not in therapeutic AChE inhibitor overdose). [cite:KD Tripathi 8e Ch 12; Longo et al. Harrison's Principles of Internal Medicine 21e Ch 479]